Trials / Completed
CompletedNCT05499026
Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)
Retrospective Cohort Study to Investigate the Safety and Efficacy of Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- Leadiant Biosciences Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Retrospective study of CTX patients to investigate the safety and clinical efficacy of Chenodeoxycholic Acid
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chenodeoxycholic Acid | Bile acid |
Timeline
- Start date
- 2014-12-09
- Primary completion
- 2015-06-03
- Completion
- 2015-06-03
- First posted
- 2022-08-12
- Last updated
- 2022-08-12
Source: ClinicalTrials.gov record NCT05499026. Inclusion in this directory is not an endorsement.